| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2022-09-22 17:43:42 UTC |
|---|
| HMDB ID | HMDB0000387 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 3-Hydroxydodecanoic acid |
|---|
| Description | 3-Hydroxydodecanoic acid (CAS: 1883-13-2) is a medium-chain fatty acid associated with fatty acid metabolic disorders (PMID: 11948802 ). Deficiency of medium-chain acyl-CoA dehydrogenase is characterized by an intolerance to prolonged fasting, recurrent episodes of hypoglycemic coma with medium-chain dicarboxylic aciduria, impaired ketogenesis, and low plasma and tissue carnitine levels (OMIM: 201450 ). 3-Hydroxydodecanoic acid is also a microbial metabolite found in Acinetobacter, Moraxella, and Pseudomonas (PMID: 21687748 ). 3-Hydroxydodecanoic acid has been identified in the human placenta (PMID: 32033212 ). |
|---|
| Structure | InChI=1S/C12H24O3/c1-2-3-4-5-6-7-8-9-11(13)10-12(14)15/h11,13H,2-10H2,1H3,(H,14,15)/t11-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (S)-3-Hydroxydodecanoic acid | ChEBI | | (S)-3-OH Dodecanoic acid | ChEBI | | (S)-3-OH Lauric acid | ChEBI | | (S)-beta-Hydroxydodecanoic acid | ChEBI | | (S)-beta-Hydroxylauric acid | ChEBI | | (S)-beta-OH Dodecanoic acid | ChEBI | | (S)-beta-OH Lauric acid | ChEBI | | (S)-3-Hydroxydodecanoate | Generator | | (S)-3-OH Dodecanoate | Generator | | (S)-3-OH Laate | Generator | | (S)-3-OH Laic acid | Generator | | (S)-b-Hydroxydodecanoate | Generator | | (S)-b-Hydroxydodecanoic acid | Generator | | (S)-beta-Hydroxydodecanoate | Generator | | (S)-Β-hydroxydodecanoate | Generator | | (S)-Β-hydroxydodecanoic acid | Generator | | (S)-b-Hydroxylaate | Generator | | (S)-b-Hydroxylaic acid | Generator | | (S)-beta-Hydroxylaate | Generator | | (S)-beta-Hydroxylaic acid | Generator | | (S)-Β-hydroxylaate | Generator | | (S)-Β-hydroxylaic acid | Generator | | (S)-b-OH Dodecanoate | Generator | | (S)-b-OH Dodecanoic acid | Generator | | (S)-beta-OH Dodecanoate | Generator | | (S)-Β-OH dodecanoate | Generator | | (S)-Β-OH dodecanoic acid | Generator | | (S)-b-OH Laate | Generator | | (S)-b-OH Laic acid | Generator | | (S)-beta-OH Laate | Generator | | (S)-beta-OH Laic acid | Generator | | (S)-Β-OH laate | Generator | | (S)-Β-OH laic acid | Generator | | 3-Hydroxydodecanoate | Generator | | (S)-3-Hydroxylaate | HMDB | | (S)-3-Hydroxylaic acid | HMDB | | (3S)-3-Hydroxydodecanoate | HMDB | | (3S)-3-Hydroxydodecanoic acid | HMDB | | (±)-3-hydroxydodecanoate | HMDB | | (±)-3-hydroxydodecanoic acid | HMDB | | 3-Hydroxylaurate | HMDB | | 3-Hydroxylauric acid | HMDB | | DL-beta-Hydroxydodecanoate | HMDB | | DL-beta-Hydroxydodecanoic acid | HMDB | | DL-Β-hydroxydodecanoate | HMDB | | DL-Β-hydroxydodecanoic acid | HMDB | | FA(12:0(3-OH)) | HMDB | | FA(12:0(3S-OH)) | HMDB | | L-3-Hydroxydodecanoate | HMDB | | L-3-Hydroxydodecanoic acid | HMDB | | beta-Hydroxydodecanoate | HMDB | | beta-Hydroxydodecanoic acid | HMDB | | beta-Hydroxylaurate | HMDB | | beta-Hydroxylauric acid | HMDB | | Β-hydroxydodecanoate | HMDB | | Β-hydroxydodecanoic acid | HMDB | | Β-hydroxylaurate | HMDB | | Β-hydroxylauric acid | HMDB | | 3-Hydroxydodecanoic acid | HMDB |
|
|---|
| Chemical Formula | C12H24O3 |
|---|
| Average Molecular Weight | 216.321 |
|---|
| Monoisotopic Molecular Weight | 216.172544633 |
|---|
| IUPAC Name | (3S)-3-hydroxydodecanoic acid |
|---|
| Traditional Name | (S)-3-hydroxylauric acid |
|---|
| CAS Registry Number | 45162-48-9 |
|---|
| SMILES | CCCCCCCCC[C@H](O)CC(O)=O |
|---|
| InChI Identifier | InChI=1S/C12H24O3/c1-2-3-4-5-6-7-8-9-11(13)10-12(14)15/h11,13H,2-10H2,1H3,(H,14,15)/t11-/m0/s1 |
|---|
| InChI Key | MUCMKTPAZLSKTL-NSHDSACASA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Hydroxy acids and derivatives |
|---|
| Sub Class | Medium-chain hydroxy acids and derivatives |
|---|
| Direct Parent | Medium-chain hydroxy acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Medium-chain hydroxy acid
- Medium-chain fatty acid
- Beta-hydroxy acid
- Hydroxy fatty acid
- Fatty acyl
- Fatty acid
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic oxide
- Alcohol
- Carbonyl group
- Hydrocarbon derivative
- Organic oxygen compound
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.74 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.3627 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.63 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 39.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2175.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 325.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 159.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 185.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 379.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 591.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 568.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 100.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1186.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 436.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1390.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 396.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 358.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 388.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 252.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 59.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3-Hydroxydodecanoic acid,1TMS,isomer #1 | CCCCCCCCC[C@@H](CC(=O)O)O[Si](C)(C)C | 1780.9 | Semi standard non polar | 33892256 | | 3-Hydroxydodecanoic acid,1TMS,isomer #2 | CCCCCCCCC[C@H](O)CC(=O)O[Si](C)(C)C | 1767.4 | Semi standard non polar | 33892256 | | 3-Hydroxydodecanoic acid,2TMS,isomer #1 | CCCCCCCCC[C@@H](CC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 1855.5 | Semi standard non polar | 33892256 | | 3-Hydroxydodecanoic acid,1TBDMS,isomer #1 | CCCCCCCCC[C@@H](CC(=O)O)O[Si](C)(C)C(C)(C)C | 2007.2 | Semi standard non polar | 33892256 | | 3-Hydroxydodecanoic acid,1TBDMS,isomer #2 | CCCCCCCCC[C@H](O)CC(=O)O[Si](C)(C)C(C)(C)C | 2000.8 | Semi standard non polar | 33892256 | | 3-Hydroxydodecanoic acid,2TBDMS,isomer #1 | CCCCCCCCC[C@@H](CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2314.9 | Semi standard non polar | 33892256 |
|
|---|
| Spectra |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - 3-Hydroxydodecanoic acid GC-MS (2 TMS) | splash10-001i-5930000000-267beffaa56f4c3885ab | 2019-10-24 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - 3-Hydroxydodecanoic acid GC-MS (Non-derivatized) | splash10-001i-5930000000-267beffaa56f4c3885ab | 2019-10-24 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxydodecanoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxydodecanoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxydodecanoic acid GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxydodecanoic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxydodecanoic acid GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxydodecanoic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxydodecanoic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxydodecanoic acid GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Hydroxydodecanoic acid Quattro_QQQ 10V, Negative-QTOF (Annotated) | splash10-0aor-9050000000-f8825f9349ee9a2ec34e | 2019-10-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Hydroxydodecanoic acid Quattro_QQQ 25V, Negative-QTOF (Annotated) | splash10-0a4i-9000000000-3d142f4358076fbe5192 | 2019-10-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 3-Hydroxydodecanoic acid Quattro_QQQ 40V, Negative-QTOF (Annotated) | splash10-0a4i-9000000000-54e9a813b1c73a4dee86 | 2019-10-24 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxydodecanoic acid 10V, Positive-QTOF | splash10-014i-9640000000-6ae3522b4ab714ac01d9 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxydodecanoic acid 20V, Positive-QTOF | splash10-0ab9-9000000000-f44f1941ba69e47860fb | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxydodecanoic acid 40V, Positive-QTOF | splash10-0a4l-9000000000-7aa76d51356623cc325f | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxydodecanoic acid 10V, Negative-QTOF | splash10-066r-7090000000-c136666cfe0af2c7d044 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxydodecanoic acid 20V, Negative-QTOF | splash10-0a4i-9000000000-918089033fd82836fb6f | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxydodecanoic acid 40V, Negative-QTOF | splash10-0006-9000000000-efd0e0c3d7b6aa45f62c | 2021-09-24 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2019-10-24 | Wishart Lab | View Spectrum | | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, 5%_DMSO, experimental) | 2019-10-24 | Wishart Lab | View Spectrum |
|
|---|
| Biological Properties |
|---|
| Cellular Locations | - Extracellular
- Membrane (predicted from logP)
|
|---|
| Biospecimen Locations | |
|---|
| Tissue Locations | |
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 0.3 (0.2-0.6) uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 0.4 (0.2-1.4) uM | Not Available | Not Available | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 0.4 (0.2-1.4) uM | Adult (>18 years old) | Both | Fatty Acid Oxidation disorder with supplementation of MCT formula | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Nonalcoholic fatty liver disease (NAFLD) | | details | | Urine | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Cancer patients undergoing total body irradiation | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Fatty Acid Oxidation disorder |
|---|
- Jones PM, Quinn R, Fennessey PV, Tjoa S, Goodman SI, Fiore S, Burlina AB, Rinaldo P, Boriack RL, Bennett MJ: Improved stable isotope dilution-gas chromatography-mass spectrometry method for serum or plasma free 3-hydroxy-fatty acids and its utility for the study of disorders of mitochondrial fatty acid beta-oxidation. Clin Chem. 2000 Feb;46(2):149-55. [PubMed:10657369 ]
| | Nonalcoholic fatty liver disease |
|---|
- Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, Bailey J, Myers RP, Rioux KP: Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013 Jul;11(7):868-75.e1-3. doi: 10.1016/j.cgh.2013.02.015. Epub 2013 Feb 27. [PubMed:23454028 ]
|
|
|---|
| Associated OMIM IDs | None |
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB022005 |
|---|
| KNApSAcK ID | Not Available |
|---|
| Chemspider ID | 4472230 |
|---|
| KEGG Compound ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| Wikipedia Link | Not Available |
|---|
| METLIN ID | 5376 |
|---|
| PubChem Compound | 5312805 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 36210 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| MarkerDB ID | Not Available |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Iwata, Tsutomu; Iwamoto, Osamu; Sugiyama, Haruhiko. Process for preparing b-hydroxy fatty acid. Eur. Pat. Appl. (1990), 6 pp. |
|---|
| Material Safety Data Sheet (MSDS) | Download (PDF) |
|---|
| General References | - Chickos JS, Way BA, Wilson J, Shaharuzzaman M, Laird J, Landt M: Analysis of 3-hydroxydodecanedioic acid for studies of fatty acid metabolic disorders: preparation of stable isotope standards. J Clin Lab Anal. 2002;16(2):115-20. [PubMed:11948802 ]
- Jones PM, Quinn R, Fennessey PV, Tjoa S, Goodman SI, Fiore S, Burlina AB, Rinaldo P, Boriack RL, Bennett MJ: Improved stable isotope dilution-gas chromatography-mass spectrometry method for serum or plasma free 3-hydroxy-fatty acids and its utility for the study of disorders of mitochondrial fatty acid beta-oxidation. Clin Chem. 2000 Feb;46(2):149-55. [PubMed:10657369 ]
- Jones PM, Moffitt M, Joseph D, Harthcock PA, Boriack RL, Ibdah JA, Strauss AW, Bennett MJ: Accumulation of free 3-hydroxy fatty acids in the culture media of fibroblasts from patients deficient in long-chain l-3-hydroxyacyl-CoA dehydrogenase: a useful diagnostic aid. Clin Chem. 2001;47(7):1190-4. [PubMed:11427448 ]
- Ktsoyan ZA, Beloborodova NV, Sedrakyan AM, Osipov GA, Khachatryan ZA, Kelly D, Manukyan GP, Arakelova KA, Hovhannisyan AI, Olenin AY, Arakelyan AA, Ghazaryan KA, Aminov RI: Profiles of Microbial Fatty Acids in the Human Metabolome are Disease-Specific. Front Microbiol. 2011 Jan 20;1:148. doi: 10.3389/fmicb.2010.00148. eCollection 2010. [PubMed:21687748 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
|---|